[Optimization of composition and concentration for lyophlizing protectant of human red blood cells].
This study was purposed to investigate the effect of different compositions and concentrations of lyophilizing protectants on recovery of RBCs and hemoglobin (Hb) after rehydration of lyophilized RBCs. The RBC lyophilizing protectants composed of a series concentrations of PVP, trehalose and different osmotic protectants were applied for protecting lyophilizing process of RBCs, the recovery of RBCs and Hb after rehydration of lyophilized RBCs was detected. The results showed that there were significant differences in loss ratio of RBCs between protectants composed of different compositions and concentrations (p<0.05 or p<0.01). The loss ratio of RBCs in protectant containing 30% PVP40, 150 mmol/L trehalose and 2% BSA was minimum (0.02%), the loss ratio of RBCs in protectant containing 6% PVP 360, 100 mmol/L trehalose and 2% BSA was maximum (0.27%). The difference of effect between 150 and 50 mmol/L trehalose was statistically significant (p<0.01). The recovery rates of RBCs and Hb in protectants contained PVP40 of different concentrations were different after rehydration of lyophilized RBCs. The protectant containing 15% PVP40, 150 mmol/L trehalose and 2% BSA showed optimal protective efficacy for lyophilized RBCs, the recovery rates of RBCs and Hb were 61.29+/-4.11% and 62.49+/-5.91% respectively, which were statistically different from other protectants (p<0.01). The protectants containing glycerol displayed best efficiency in lyophilization too, the recovery rates of RBCs and Hb were 65.97+/-4.52% and 67.24+/-5.94%, respectively. It is concluded that the protectants composed of 0.8 mol/L glycerol, 15% PVP40, 150 mmol/L trehalose and 2% BSA (pH 7.3 ) may be used as the protectant lyophilizing human RBCs in future study.
Department of Transfusion, Chinese PLA General Hospital, Beijing 100853, China.
Lin-Feng
LF
Chen
Jing-Han
JH
Liu
Xi-Lin
XL
Ouyang
Yuan
Y
Zhuang
Ji
J
Che
Yang
Y
Yu
D001793:Blood Preservation / Q000379:methods; D003451:Cryoprotective Agents / Q000008:administration & dosage* / Q000032:analysis*; D004912:Erythrocytes; D005612:Freeze Drying / Q000379:methods; D006801:Humans; D014199:Trehalose / Q000008:administration & dosage / Q000032:analysis
D003451:Cryoprotective Agents; D014199:Trehalose